A Pharmacologic Off-Switch for Split CARs - Top-Institutions - MDSpire

A Pharmacologic Off-Switch for Split CARs

Study describes a venetoclax-regulated off-switch CAR system with dose-dependent control of receptor assembly in vitro and in vivo

  • March 3, 2026

  • 2 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Immuno-oncology
    • Cellular Therapy
    • Protein Engineering

  • #2

    University of Pennsylvania Perelman School of Medicine
    University of Pennsylvania Perelman School of Medicine

    Philadelphia, PA

    Key Differentiators

    • Cellular Therapy
    • Immunology
    • Synthetic Biology

  • #3

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, CA

    Key Differentiators

    • Immuno-oncology
    • Protein Engineering
    • Cellular Therapy

  • #4

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Cellular Therapy
    • Immunotherapy
    • Cancer Biology

  • #5

    Massachusetts General Hospital Cancer Center
    Massachusetts General Hospital Cancer Center

    Boston, MA

    Key Differentiators

    • Immuno-oncology
    • Cellular Therapy
    • Translational Medicine

Original Source(s)

A Pharmacologic Off-Switch for Split CARs

  • March 3, 2026

Related Content

Disease site as an independent predictor of survival in radioiodine-refractory thyroid cancer

Multimodal treatment and long-term survival in a rare case of melanoma with pancreatic and splenic metastases: a case report and literature review

Editorial: Exploring unconventional T cells and CAR-T-cells in cancer immunotherapy